Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Bioventus amends IPO

    Bioventus Inc., Durham, N.C. Business: Musculoskeletal, Neurology Date announced: 2016-07-19 Type: IPO To be raised: Up to $158.8 million Shares: 8.8 million Price: $16-$18 Underwriters: JPMorgan; Piper Jaffray; Stifel,…

    Published on 7/25/2016
  • Audentes Therapeutics completes IPO

    Audentes Therapeutics Inc. (NASDAQ:BOLD), San Francisco, Calif. Business: Gene/Cell therapy, Cardiovascular, Endocrine/Metabolic Date completed: 2016-07-19 Type: IPO Raised: $75 million Shares: 5 million Price: $15 …

    Published on 7/25/2016
  • Auris Medical completes debt financing

    Auris Medical Holding AG (NASDAQ:EARS), Zug, Switzerland Business: Other Date completed: 2016-07-19 Type: Debt financing Raised: $12.5 million Investor: Hercules Capital Note: Auris drew down $12.5 million in a first …

    Published on 7/25/2016
  • ContraFect completes follow-on

    ContraFect Corp. (NASDAQ:CFRX), Yonkers, N.Y. Business: Antibodies, Infectious Date completed: 2016-07-22 Type: Follow-on Raised: $35 million Shares: 14 million Price: $2.50 Shares after offering: 41.5 million …

    Published on 7/25/2016
  • Endonovo Therapeutics completes private placement of senior convertible notes

    Endonovo Therapeutics Inc. (OTCQB:ENDV), Woodland Hills, Calif. Business: Inflammation, Autoimmune Date completed: 2016-07-15 Type: Private placement of senior convertible notes Raised: $400,000 Shares outstanding prior…

    Published on 7/25/2016
  • Evoke Pharma completes direct public offering

    Evoke Pharma Inc. (NASDAQ:EVOK), San Diego, Calif. Business: Gastrointestinal Date completed: 2016-07-20 Type: Direct public offering Raised: $4.5 million Shares: 1.8 million Price: $2.49 Shares after offering: 9 …

    Published on 7/25/2016
  • Fulcrum Therapeutics completes venture financing

    Fulcrum Therapeutics Inc., Cambridge, Mass. Business: Neurology, Musculoskeletal, Cardiovascular Date completed: 2016-07-19 Type: Venture financing Raised: $55 million Investor: Third Rock Ventures

    Published on 7/25/2016
  • Genexine completes convertible debt financing

    Genexine Inc. (KOSDAQ:095700), Seoul, South Korea Business: Endocrine/Metabolic, Cancer, Hematology Date completed: 2016-06-29 Type: Convertible debt financing Raised: W20 billion ($18 million) Investors: Tasly …

    Published on 7/25/2016
  • Genexine completes private placement of convertible preferred stock

    Genexine Inc. (KOSDAQ:095700), Seoul, South Korea Business: Endocrine/Metabolic, Cancer, Hematology Date completed: 2016-06-29 Type: Private placement of convertible preferred stock Raised: W60 billion ($54 million) …

    Published on 7/25/2016
  • InflaRx completes venture financing

    InflaRx GmbH, Jena, Germany Business: Infectious, Inflammation Date completed: 2016-07-21 Type: Venture financing Raised: EUR31 million ($34.3 million) Investors: Staidson Hong Kong Investment Co. Ltd.; existing …

    Published on 7/25/2016
  • Innovus completes private placement of convertible notes

    Innovus Pharmaceuticals Inc. (OTCBB:INNV), San Diego, Calif. Business: Cancer, Dermatology Date completed: 2016-07-18 Type: Private placement of convertible notes Raised: $750,000 Shares outstanding prior: 73.2 million …

    Published on 7/25/2016
  • N-of-One completes venture financing

    N-of-One Inc., Lexington, Mass. Business: Genomics, Cancer Date completed: 2016-07-21 Type: Venture financing Raised: $7 million Investors: Providence Ventures; Excel Venture Management

    Published on 7/25/2016
  • Oncorus completes venture financing

    Oncorus Inc., Cambridge, Mass. Business: Cancer Date completed: 2016-07-19 Type: Venture financing Raised: $57 million Investors: MPM Capital; Deerfield Management; Arkin Holdings; Celgene Corp.; Excelyrate Capital; …

    Published on 7/25/2016
  • Patheon completes IPO

    Patheon N.V. (NYSE:PTHN), Amsterdam, the Netherlands Business: Supply/Service Date completed: 2016-07-20 Type: IPO Raised: $525 million Shares: 25 million Price: $21 Shares after offering: 140.6 million Underwriters: …

    Published on 7/25/2016
  • Poxel completes private placement

    Poxel S.A. (Euronext:POXEL), Lyon, France Business: Endocrine/Metabolic, Infectious Date completed: 2016-07-18 Type: Private placement Raised: EUR26.5 million ($29.3 million) Shares: 3.4 million Price: EUR7.80 Shares …

    Published on 7/25/2016
  • Sygnis completes private placement

    Sygnis AG (Xetra:LIO1), Heidelberg, Germany Business: Genomics, Supply/Service Date completed: 2016-07-14 Type: Private placement Raised: EUR2 million ($2.2 million) Shares: 1.8 million Price: EUR1.10 Shares after …

    Published on 7/25/2016
  • Sygnis completes rights offering

    Sygnis AG (Xetra:LIO1), Heidelberg, Germany Business: Genomics, Supply/Service Date completed: 2016-07-14 Type: Rights offering Raised: EUR3.3 million ($3.7 million) Shares: 3 million Price: EUR1.10 Shares after …

    Published on 7/25/2016
  • Synthorx completes venture financing

    Synthorx Inc., La Jolla, Calif. Business: Cancer, Infectious, Diagnostic Date completed: 2016-07-20 Type: Venture financing Raised: $10 million Investors: RA Capital Management; Avalon Ventures; Correlation Ventures

    Published on 7/25/2016
  • Teva completes private placement of senior notes

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Autoimmune, Neurology, Biosimilars Date completed: 2016-07-18 Type: Private placement of senior notes Raised: $15 billion Underwriters: …

    Published on 7/25/2016
  • Teva completes private placement of senior notes

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Autoimmune, Neurology, Biosimilars Date completed: 2016-07-20 Type: Private placement of senior notes Raised: EUR4 billion ($4.4 billion) …

    Published on 7/25/2016
  • Teva completes private placement of senior notes

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Autoimmune, Neurology, Biosimilars Date completed: 2016-07-21 Type: Private placement of senior notes Raised: CHF1 billion ($1 billion) Note…

    Published on 7/25/2016
  • Biocartis financial update

    Biocartis Group N.V. (Euronext:BCART), Mechelen, Belgium Business: Diagnostic Date announced: 2016-07-20 Note: Biocartis secured a new EUR15 million ($16.6 million), five-year lease financing facility; a new EUR15 …

    Published on 7/25/2016
  • Emergent BioSolutions financial update

    Emergent BioSolutions Inc. (NYSE:EBS), Rockville, Md. Business: Infectious, Cancer, Hematology Date announced: 2016-07-15 Note: Emergents board authorized a share repurchase program of up to $50 million. The company, …

    Published on 7/25/2016
  • Endonovo Therapeutics financial update

    Endonovo Therapeutics Inc. (OTCQB:ENDV), Woodland Hills, Calif. Business: Inflammation, Autoimmune Date announced: 2016-07-15 Note: Endonovo entered into a $9 million equity purchase agreement with Bellridge Capital.

    Published on 7/25/2016
  • GW Pharma financial update

    GW Pharmaceuticals plc (LSE:GWP; NASDAQ:GWPH), Salisbury, U.K. Business: Neurology, Endocrine/Metabolic, Cancer Date announced: 2016-07-18 Note: GW Pharmaceuticals raised $37.8 million through the sale of 420,000 ADSs …

    Published on 7/25/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993